Fig. 3: Mean difference in FEV1.
From: Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
ALAACRC American Lung Association Asthma Clinical Research Centers, AUC area under curve, BID twice daily, CI confidence interval, FEV1 forced expiratory volume in 1 s, LABA long-acting β2-agonist, LAMA long-acting muscarinic agonist, LTRA leukotriene receptor antagonist, NR not reported, NS non-significant, QD once daily.
